Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lynch

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Seminars in Oncology|February 1, 2017
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trialsFrances A Shepherd, Frank V Fossella, Thomas Lynch, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II studyNoah Choi, Sung D Park, Thomas Lynch, et al.
BMJ Supportive & Palliative Care|July 18, 2015
Why don't end-of-life conversations go viral? A review of videos on YouTubeImogen A Mitchell, Anne L R Schuster, Thomas Lynch, et al.
Heliyon|July 22, 2016
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cellsArmelle Meunier, Victoria Anastasia Belle, Niamh McDermott, et al.
Journal of Pain and Symptom Management|May 8, 2007
Funding for palliative care programs in developing countriesMary Callaway, Kathleen M Foley, Liliana De Lima, et al.
BMC Palliative Care|March 29, 2018
A review of paper-based advance care planning aidsJohn F P Bridges, Thomas Lynch, Anne L R Schuster, et al.
The Prostate|June 22, 2010
In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancerTherese M Murphy, Linda Sullivan, Caroline Lane, et al.
The Journal of Urology|August 22, 2012
IGFBP7 promoter methylation and gene expression analysis in prostate cancerLinda Sullivan, Therese M Murphy, Ciara Barrett, et al.
The Oncologist|November 6, 2008
Racism in the chemotherapy infusion unit: a nurse's storyLidia Schapira, Leah Gordon-Rowe, Rosalba Martignetti, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancerNoah C Choi, Alan J Fischman, Andrzej Niemierko, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Seminars in Oncology|February 1, 2017
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trialsFrances A Shepherd, Frank V Fossella, Thomas Lynch, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II studyNoah Choi, Sung D Park, Thomas Lynch, et al.
BMJ Supportive & Palliative Care|July 18, 2015
Why don't end-of-life conversations go viral? A review of videos on YouTubeImogen A Mitchell, Anne L R Schuster, Thomas Lynch, et al.
Heliyon|July 22, 2016
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cellsArmelle Meunier, Victoria Anastasia Belle, Niamh McDermott, et al.
Journal of Pain and Symptom Management|May 8, 2007
Funding for palliative care programs in developing countriesMary Callaway, Kathleen M Foley, Liliana De Lima, et al.
BMC Palliative Care|March 29, 2018
A review of paper-based advance care planning aidsJohn F P Bridges, Thomas Lynch, Anne L R Schuster, et al.
The Prostate|June 22, 2010
In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancerTherese M Murphy, Linda Sullivan, Caroline Lane, et al.
The Journal of Urology|August 22, 2012
IGFBP7 promoter methylation and gene expression analysis in prostate cancerLinda Sullivan, Therese M Murphy, Ciara Barrett, et al.
The Oncologist|November 6, 2008
Racism in the chemotherapy infusion unit: a nurse's storyLidia Schapira, Leah Gordon-Rowe, Rosalba Martignetti, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancerNoah C Choi, Alan J Fischman, Andrzej Niemierko, et al.
Pageof 10